Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Short Interest Update

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) was the target of a significant growth in short interest in July. As of July 31st, there was short interest totaling 5,913 shares, a growth of 53.0% from the July 15th total of 3,865 shares. Based on an average daily volume of 3,042 shares, the days-to-cover ratio is currently 1.9 days. Approximately 4.5% of the shares of the stock are sold short.

Insiders Place Their Bets

In other Bitwise MARA Option Income Strategy ETF news, insider Helen Louise Collins sold 5,000 shares of the company’s stock in a transaction that occurred on Friday, July 17th. The shares were sold at an average price of $52.67, for a total value of $263,350.00. Following the completion of the transaction, the insider directly owned 25,000 shares in the company, valued at $1,316,750. This represents a 16.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, major shareholder Orbimed Advisors Llc sold 860,123 shares of the stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $45.36, for a total transaction of $39,015,179.28. Following the completion of the sale, the insider directly owned 219,405 shares of the company’s stock, valued at approximately $9,952,210.80. This trade represents a 79.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 1,342,362 shares of company stock valued at $63,158,240. Insiders own 37.30% of the company’s stock.

Bitwise MARA Option Income Strategy ETF Stock Performance

IMRA opened at $14.59 on Tuesday. The stock has a market cap of $1.90 million, a price-to-earnings ratio of 291.80 and a beta of 2.74. The firm’s fifty day moving average is $15.72 and its 200 day moving average is $15.26. Bitwise MARA Option Income Strategy ETF has a fifty-two week low of $11.99 and a fifty-two week high of $42.32.

About Bitwise MARA Option Income Strategy ETF

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.